Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line Treatment

Abroad (travel likely)RecruitingPHASE3

Conditions

Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fujian Cancer Hosptial, Fuzhou, Fujian, China
Contact: Study coordinator (Chuangui Song) · songcg1971@outlook.com · 13960709993

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

BRE-08 Phase II Study of CMC Regimen for Early Stage Breast Cancer

Breast Cancer

Abroad (travel likely)RecruitingPHASE2

Chicago, United States

BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease

HR+/HER2- Breast Cancer

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Anchorage, United States

A Trial Comparing GQ1005 and T-DM1 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer

HER2-positive Breast Cancer

Abroad (travel likely)RecruitingPHASE3

Bengbu, China · Fuyang, China

Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant Ribociclib

Breast Cancer

Abroad (travel likely)RecruitingPHASE3

Amiens, France · Angers, France